Earnings History Data for ARCA biopharma, Inc. (ABIO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ARCA biopharma, Inc.
ARCA biopharma, Inc., a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular science, ARCA's management team has significant experience in developing and commercializing cardiovascular products. The Company's business focus combines expertise in cardiovascular pathophysiology, molecular genetics, clinical development and product commercialization. It is currently developing Gencaro (bucindolol hydrochloride), a cardiovascular drug for the treatment of chronic heart failure. The company is based in Broomfield, Colorado.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02-08-2022 | AH | 4:30 PM ET (Aug 2) |
ABIO | ARCA biopharma, Inc. | 34.73 | -0.22 | 0.00 | -0.34 | ARCA biopharma GAAP EPS of -$0.22 [8/2/2022 5:15 PM] |
2.34 | 0.01 (0.43%) |
0.0 | 0.0 (0.00%) |
1.71 - 3.24 | 53,133 | 40,000 | 0 | |
| 02-11-2021 | AH | 4:30 PM ET (Nov 2) |
ABIO | ARCA biopharma, Inc. | 37.75 | -0.33 | 0.00 | -0.33 | ARCA biopharma reports Q3 results [11/2/2021 4:54 PM] |
2.62 | -0.03 (-1.13%) |
2.62 | -0.03 (-1.13%) |
2.55 - 5.50 | 291,095 | 1,540,000 | 24,442 | |
|
||||||||||||||||||
| 11-05-2021 | AH | 4:30 PM ET (May 11) |
ABIO | ARCA biopharma, Inc. | 44.10 | -0.33 | 0.00 | -0.83 | ARCA biopharma reports Q1 results [5/11/2021 4:31 PM] |
3.19 | 0.07 (2.24%) |
3.12 | 0.0 (0.00%) |
2.92 - 22.00 | 745,719 | 350,000 | 25,572 | |
| 02-11-2020 | PM | ABIO | ARCA biopharma, Inc. | 37.75 | -0.33 | 0.00 | -0.76 | ARCA biopharma reports Q3 results [11/2/2020 8:37 AM] |
3.99 | -0.04 (-0.99%) |
4.00 | -0.03 (-0.74%) |
2.21 - 22.00 | 214,915 | 332,275 | 19,311 | ||
|
|
||||||||||||||||||